Coronado Biosciences Inc (NASDAQ:CNDO) reversed its recent downward trend yesterday with the stock declining 2.66% or $0.11 to finish the day at $4.03 on light trading volume of 0.318 million, compared to its 30 day average trading volume of 1.78 million. The auto-immune treatment developer’s decrease in value came despite the fact that the company did not make any significant announcements or release any financial figures. . Coronado Biosciences Inc is now up 65.16% for the year so far, outstripping the S&P 500 which is only up 1.79% for the same period. With the BioSciences sector already the newest darling of Wall Street, this stock in particular has the potential to be a good medium to long term investment, making it a buy at this time.
Are Coronado Biosciences Inc’s Gains Backed Up By Strong Fundamentals? Get The